Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells

Journal of Cellular Physiology

Volumn 227, Issue 4, 2012, Pages 1399-1407

  Zuo, Yufeng ^a   Wu, Yuexiu ^a   Chakraborty, Chandan ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN CDC42; PROTEIN KINASE C; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION;

BASE SEQUENCE; BREAST NEOPLASMS; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PROTEIN KINASE C-DELTA; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING;

EID: 84862973298     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22853     Document Type: Article

References (56)

1. Bernt KM, Ni S, Tieu AT, Lieber A. 2005. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy. Cancer Res 65:4343-4352.
2. Bishop AL, Hall A. 2000. Rho GTPases and their effector proteins. Biochem J 348:241-255.
3. Breitkreutz D, Braiman-Wiksman L, Daum N, Denning MF, Tennenbaum T. 2007. Protein kinase C family: On the crossroads of cell signaling in skin and tumor epithelium. J Cancer Res Clin Oncol 133:793-808.
4. Bustelo XR, Sauzeau V, Berenjeno IM. 2007. GTP-binding proteins of the Rho/Rac family: Regulation, effectors and functions in vivo. Bioessays 29:356-370.
5. Chahdi A, Miller B, Sorokin A. 2005. Endothelin 1 induces beta 1Pix translocation and Cdc42 activation via protein kinase A-dependent pathway. J Biol Chem 280:578-584.
6. Chambers AF, Groom AC, MacDonald IC. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572.
7. Chen F, Ma L, Parrini MC, Mao X, Lopez M. Wu C, et al. 2000. Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol 10:758-765.
8. Chen TJ, Gehler S, Shaw AE, Bamburg JR, Letourneau PC. 2006. Cdc42 participates in the regulation of ADF/cofilin and retinal growth cone filopodia by brain derived neurotrophic factor. J Neurobiol 66:103-114.
9. Cheng X, Ma Y, Moore M, Hemmings BA, Taylor SS. 1998. Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase. Proc Natl Acad Sci USA 95:9849-9854.
10. Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E, et al. 2000. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406:742-747.
11. Cotteret S, Chernoff J. 2002. The evolutionary history of effectors downstream of Cdc42 and Rac. Genome Biol 3: REVIEWS 0002. 1-8.
12. Doolan CM, Condliffe SB, Harvey BJ. 2000. Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon. Br J Pharmacol 129:1375-1386.
13. Ellenbroek SI, Collard JG. 2007. Rho GTPases: Functions and association with cancer. Clin Exp Metastasis 24:657-672.
14. Feoktistov I, Goldstein AE, Biaggioni I. 2000. Cyclic AMP and protein kinase A stimulate Cdc42: Role of A(2) adenosine receptors in human mast cells. Mol Pharmacol 58:903-910.
15. Fritz G, Just I, Kaina B. 1999. Rho GTPases are over-expressed in human tumors. Int J Cancer 81:682-687.
16. Frost JA, Steen H, Shapiro P, Lewis T, Ahn N, Shaw PE, et al. 1997. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J 16:6426-6438.
17. Gildea JJ, Harding MA, Seraj MJ, Gulding KM, Theodorescu D. 2002. The role of Ral A in epidermal growth factor receptor-regulated cell motility. Cancer Res 62:982-985.
18. Gomez DP, Benitah SA, Valeron PF, Espina C, Lacal JC. 2005. Rho GTPase expression in tumourigenesis: Evidence for a significant link. Bioessays 27:602-613.
19. Hirsch DS, Shen Y, Wu WJ. 2006. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. Cancer Res 66:3523-3530.
20. Hordijk PL, ten Klooster JP, van der Kammen RA, Michiels F, Oomen LC, Collard JG. 1997. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 278:1464-1466.
21. 2. Cell Signal 19:410-418.
22. Huang C, Jacobson K, Schaller MD. 2004. MAP kinases and cell migration. J Cell Sci 117:4619-4628.
23. Hwang SY, Jung JW, Jeong JS, Kim YJ, Oh ES, Kim TH, et al. 2006. Dominant-negative Rac increases both inherent and ionizing radiation-induced cell migration in C6 rat glioma cells. Int J Cancer 118:2056-2063.
24. Jadeski LC, Lala PK. 1999. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol 155:1381-1390.
25. Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K, et al. 2003. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 9:6432-6440.
26. Joberty G, Perlungher RR, Sheffield PJ, Kinoshita M, Noda M, Haystead T, et al. 2001. Borg proteins control septin organization and are negatively regulated by Cdc42. Nat Cell Biol 3:861-866.
27. Johnson DA, Akamine P, Radzio-Andzelm E, Madhusudan M, Taylor SS. 2001. Dynamics of cAMP-dependent protein kinase. Chem Rev 101:2243-2270.
28. Keshamouni VG, Mattingly RR, Reddy KB. 2002. Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 and PKC-delta. J Biol Chem 277:22558-22565.
29. Kho DH, Bae JA, Lee JH, Cho HJ, Cho SH, Lee JH, et al. 2009. KITENIN recruits Dishevelled/PKC delta to form a functional complex and controls the migration and invasiveness of colorectal cancer cells. Gut 58:509-519.
30. Kiley SC, Clark KJ, Duddy SK, Welch DR, Jaken S. 1999a. Increased protein kinase C delta in mammary tumor cells: Relationship to transformtion and metastatic progression. Oncogene 18:6748-6757.
31. Kiley SC, Clark KJ, Goodnough M, Welch DR, Jaken S. 1999b. Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res 59:3230-3238.
32. 2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA 98:6587-6592.
33. Lacroix M, Leclercq G. 2004. Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res Treat 83:249-289.
34. Lala PK, Parhar RS. 1993. Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy. Int J Cancer 54:677-684.
35. Merajver SD, Usmani SZ. 2005. Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia 10:291-298.
36. Modzelewska K, Newman LP, Desai R, Keely PJ. 2006. Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas. J Biol Chem 281:37527-37535.
37. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527.
38. O'Connor KL, Mercurio AM. 2001. Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J Biol Chem 276:47895-47900.
39. O'Connor KL, Nguyen BK, Mercurio AM. 2000. RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism. J Cell Biol 148:253-258.
40. Parekh D, Ziegler W, Yonezawa K, Hara K, Parker PJ. 1999. Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon. J Biol Chem 274:34758-34764.
41. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. 2003. Cell migration: Integrating signals from front to back. Science 302:1704-1709.
42. Rovida E, Navari N, Caligiuri A, Dello SP, Marra F. 2008. ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J Hepatol 48:107-115.
43. Saarloos MN, Khoo NK, Lala PK. 1993. Effects of histamine type 2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis. Clin Exp Metastasis 11:275-283.
44. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG. 1999. Rac downregulates Rho activity: Reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 147:1009-1022.
45. Sigal YJ, Quintero OA, Cheney RE, Morris AJ. 2007. Cdc42 and ARP2/3-independent regulation of filopodia by an integral membrane lipid-phosphatase-related protein. J Cell Sci 120:340-352.
46. Szczur K, Xu H, Atkinson S, Zheng Y, Filippi MD. 2006. Rho GTPase CDC42 regulates directionality and random movement via distinct MAPK pathways in neutrophils. Blood 108:4205-4213.
47. Tang Y, Olufemi L, Wang MT, Nie D. 2008. Role of Rho GTPases in breast cancer. Front Biosci 13:759-776.
48. Timoshenko AV, Lala PK, Chakraborty C. 2004. PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors. Int J Cancer 108:384-389.
49. Villalonga P, Ridley AJ. 2006. Rho GTPases and cell cycle control. Growth Factors 24:159-164.
50. Walker K, Olson MF. 2005. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. Curr Opin Genet Dev 15:62-68.
51. Wells CM, Walmsley M, Ooi S, Tybulewicz V, Ridley AJ. 2004. Rac1-deficient macrophages exhibit defects in cell spreading and membrane ruffling but not migration. J Cell Sci 117:1259-1268.
52. Wilkinson S, Paterson HF, Marshall CJ. 2005. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat Cell Biol 7:255-261.
53. Yang W, Cerione RA. 1997. Cloning and characterization of a novel Cdc42-associated tyrosine kinase, ACK-2, from bovine brain. J Biol Chem 272:24819-24824.
54. Yonemoto W, McGlone ML, Grant B, Taylor SS. 1997. Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli. Protein Eng 10:915-925.
55. Zugasti O, Rul W, Roux P, Peyssonnaux C, Eychene A, Franke TF, et al. 2001. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol Cell Biol 21:6706-6717.
56. Zuo Y, Shields SK, Chakraborty C. 2006. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase. Biochem Biophys Res Commun 351:361-367.